The 2026 Myeongdong versus Japan decision goes beyond the headline price advantage and rests on five practical factors: protocol depth (single-device versus multi-device combination), device range (16 devices at Kind Global Myeongdong versus typical Japan clinic offerings), brand availability (Korean MFDS approval includes Coretox, Hyatox, Nabota, and Innotox unavailable under Japan PMDA), follow-up logistics across the Korea-Japan medical-license gap, and the regulatory framework around KFDA-approved aesthetic devices and Korea Medical Visa C-3-M policy.
Kind Global Clinic Myeongdong's device range covers HIFU (Ultherapy Prime by Merz, Shurink Universe by Classys, Oligio X by Wontech), RF (Thermage FLX by Solta, Density by Jeisys, InMode by InMode, Onda by DEKA at 2.45 GHz Coolwaves), pico-laser pigment, fractional CO2 laser, Cynosure Apogee Elite Plus diode-Nd:YAG, V-Laser by Wontech, and the full HA filler and toxin pharmacy line. Both co-directors personally treat every patient — there is no nurse delegation. Brand, lot number, total unit count or cartridge serial, and per-area treatment map are recorded on each patient chart at the time of treatment.
For patients seeking same-physician continuity after returning to Japan, the 6-month LINE Official messenger follow-up channel substitutes for in-person Korean review and works around the Korea-Japan medical-license non-mutual recognition. AREX airport rail covers Incheon to Seoul in 43 minutes, the Korea Medical Visa C-3-M permits multi-entry medical-tourism scheduling, and Korea Tourism Organization data shows 600,000-plus international patients selected Korea in 2023 with Japanese nationals representing 37.7 percent — the top single-country cohort. Same KRW price applies to international and Korean patients with zero surcharge.